deoxyglucose has been researched along with Liver Neoplasms in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (22.67) | 18.7374 |
1990's | 32 (42.67) | 18.2507 |
2000's | 7 (9.33) | 29.6817 |
2010's | 15 (20.00) | 24.3611 |
2020's | 4 (5.33) | 2.80 |
Authors | Studies |
---|---|
Cao, S; Chen, S; Hu, Y; Liu, G; Shi, H; Yang, X; Zhou, Y | 1 |
Antonio, MD; Balasubramanian, S; Belenguer, AM; Bohndiek, SE; Bollepalli, L; De Mitri, N; Hunter, CA; Joseph, J; Weber, J | 1 |
Chen, M; Dong, QZ; Gao, S; Hu, BY; Jia, HL; Li, TE; Lin, ZF; Lu, L; Pan, JJ; Qin, LX; Wang, X; Wu, C; Xu, D; Zhang, Z; Zheng, Y; Zhu, Y | 1 |
Egashira, K; Fukuda, K; Hara, Y; Hino, K; Nishina, S; Sasaki, K; Yamamura, M; Yamauchi, A | 1 |
Allaire, DM; Choueiry, F; Crist, MC; Prior, AB; Shen, M; Shi, H; Xu, M; Yang, K; Zhong, F; Zhu, J | 1 |
Bai, Y; Han, Y; Li, L; Wang, Y; Wei, X; Xie, R; Xu, T; Zhou, J; Zhu, J; Zhu, W | 1 |
Cai, H; Cao, K; Chen, Z; Li, W; Liu, X; Wang, J; Wu, L; Zhao, J | 1 |
Alves, AP; Alves, MG; Botelho, MF; Maia, CJ; Mamede, AC; Oliveira, PF; Rocha, SM | 1 |
Huang, G; Li, P; Liu, Q; Song, S; Wang, X | 1 |
Dai, C; Su, R; Tian, X; Zhang, R; Zhang, Y | 1 |
Cheng, G; Dilip, A; Gamblin, TC; Joseph, J; Kalyanaraman, B; Kunnimalaiyaan, M; Kunnimalaiyaan, S | 1 |
Artlett, CM; Loarca, L; Sassi-Gaha, S | 1 |
Liu, X; Sun, R; Wang, Q; Wang, Z; Zhang, D; Zhang, L | 1 |
Chow, EK; Ho, CM; Ho, D; Mohd Abdul Rashid, MB; Nurrul Abdullah, L; Silva, A; Toh, TB | 1 |
Chen, J; Dai, Y; Jia, L; Jiang, Z; Li, Y; Lin, L; Lu, Y; Ou, M; Shao, J; Wang, J; Xiang, L; Yang, X | 1 |
Huang, F; Luo, H; Wang, J; Wang, Z; Zhang, Y | 1 |
Ling, Y; Meng, G; Yang, Y; Zhang, S; Zhang, W; Zhu, H | 1 |
Ghoshal, K; Jacob, ST; Motiwala, T; Reyes, R; Wani, NA | 1 |
Aszalos, A; Finkel, T; Gottesman, MM; Liang, XJ; Shen, DW; Yin, JJ | 1 |
Che, XF; Miyazawa, K; Moriya, S; Tabuchi, T; Takemura, A; Tomoda, A | 1 |
GOERLICH, M; HEISE, E; KEMSIES, C | 1 |
ELZINA, NV | 1 |
Achilefu, S; Blessington, D; Chance, B; Chen, Y; Intes, X; Li, H; Liu, Q; Zhang, M; Zhang, ZH; Zheng, G; Zhou, L | 1 |
Friedlander, G; Laouari, D; Ledoux, S; Yang, R | 1 |
Chen, X; Li, J; Liu, W; Qi, D; Qiao, L; Wang, A; Wei, K; Wu, J; Xue, Q | 1 |
Gao, MT; Kou, W; Qiao, L; Wang, AQ; Wu, J; Xue, QJ; Zhou, YN | 1 |
Aoki, K; Kaburagi, Y; Saito, T; Satoh, S; Sekihara, H; Yamashita, R | 1 |
Kurtoglu, M; Lampidis, TJ; Maher, JC; Savaraj, N; Wangpaichitr, M | 1 |
Carrasquillo, JA; Larson, SM | 1 |
Welch, MJ | 1 |
Benua, RS; Brill, AB; Christman, DR; Fowler, JS; Kemeny, NE; MacGregor, RR; Som, P; Stamm, R; Wolf, AP; Yeh, SD; Yonekura, Y | 1 |
Bartha, I; Diczházi, C; Kopper, L; Ladányi, A; Lapis, K; Paku, S; Pogány, G; Rásó, E; Tímár, J; Tóvári, J | 1 |
Inokuma, T; Konishi, J; Magata, Y; Sasayama, S; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE | 1 |
Hall, K; Isaksson, M; Lindgren, BF; Stern, I | 1 |
Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
Ahlström, H; Bergh, J; Jansson, T; Långström, B; Lilja, A; Westlin, JE | 1 |
Hosokawa, C; Ikeda, H; Kamino, T; Kawabe, J; Ochi, H; Okamura, T; Onoyama, Y | 1 |
Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
Choi, Y; Hawkins, RA; Hoh, CK; Huang, SC; Wu, HM | 1 |
Inokuma, T; Konishi, J; Magata, Y; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
Ashwell, G; Morell, AG; Stockert, RJ; Weiss, P | 1 |
Campbell, MG; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
Fischman, AJ | 1 |
Cronin, B; Cunningham, D; Findlay, M; Flower, M; Hickish, T; Husband, J; Iveson, A; Ott, R; Pratt, B; Young, H | 1 |
Chu, KM; Fulham, M; Lai, DT; Sheldon, DM; Solomon, M; Stephen, MS; Storey, DW; Thompson, JF | 1 |
Hawkins, RA; Hoh, CK; Huang, SC; Phelps, ME; Wu, HM; Yao, WJ | 1 |
Bishop, AF; Smith, SM; Young, CS | 1 |
Delbeke, D; Mazer, MJ; Meranze, SG; Pinson, CW; Vitola, JV | 1 |
Dimitrakopoulou-Strauss, A; Doll, J; Gutzler, F; Irngartinger, G; Oberdorfer, F; Strauss, LG; Stremmel, W; van Kaick, G | 1 |
Ali, A; Alibazoglu, H; Fordham, E; LaMonica, G; Patel, PM | 1 |
Arildsen, RC; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
Jadvar, H; Segall, GM | 1 |
Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
Erbe, J; Plagemenn, PG; Richey, DP; Zylka, JM | 1 |
Plagemann, PG; Sheppard, JR | 1 |
Graff, JC; Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
Liu, CK; Schmied, R; Waxman, S | 1 |
Iype, PT; Siddiqi, M | 1 |
Asano, T; Enomoto, K; Hayashi, H; Isono, K; Kikuchi, T; Okazumi, S; Ozaki, M; Ryu, M; Yamamoto, H | 1 |
Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
Haney, PM; James, DE; Mueckler, M; Piper, RC; Slot, JW | 1 |
Asano, T; Enomoto, K; Fukunaga, T; Imazeki, K; Isono, K; Itoh, H; Kikuchi, T; Nagashima, T; Okazumi, S; Yamamoto, H | 1 |
Fukuda, H | 1 |
Buxton, JM; Carruthers, A; Chlapowski, FJ; Czech, MP; Harrison, SA; Helgerson, AL; MacDonald, RG | 1 |
Buxton, JM; Clancy, BM; Czech, MP; Harrison, SA | 1 |
Keller, K; Mueckler, M; Strube, M | 1 |
Cornelius, P; Lee, MD; Marlowe, M; Pekala, PH | 1 |
Abe, Y; Enomoto, K; Imazeki, K; Isono, K; Okazumi, S; Ozaki, M; Takayama, W; Yamada, S; Yamamoto, H; Yoshida, M | 1 |
Kaback, HR; Lodish, HF; Sarkar, HK; Thorens, B | 1 |
Ahonen, A; Nordman, E; Paul, R; Roeda, D | 1 |
Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK | 1 |
Erbe, J; Plagemann, PG | 1 |
4 review(s) available for deoxyglucose and Liver Neoplasms
Article | Year |
---|---|
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Deoxyglucose; Flavonoids; Glucose Transporter Type 1; Glycolysis; Humans; Imatinib Mesylate; Liver Neoplasms; Protein Kinase Inhibitors | 2019 |
Nuclear oncology 1984.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed | 1984 |
New Radiopharmaceuticals for studying liver function.
Topics: Albumins; Animals; Cricetinae; Deoxyglucose; Dogs; Fluorine; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Mice; Organotechnetium Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Rats; Rhamnose; Technetium | 1982 |
Inhibition of carrier-mediated and non-mediated permeation processes by cytochalasin B.
Topics: Animals; Biological Transport; Biological Transport, Active; Blood Glucose; Carcinoma, Hepatocellular; Cytochalasin B; Cytochalasins; Deoxyglucose; Erythrocytes; Hexoses; Humans; Kinetics; Liver Neoplasms; Methylglucosides; Neoplasms, Experimental; Rats; Thermodynamics | 1978 |
4 trial(s) available for deoxyglucose and Liver Neoplasms
Article | Year |
---|---|
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Methionine; Tomography, Emission-Computed | 1995 |
Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Necrosis; Tomography, Emission-Computed | 1994 |
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Double-Blind Method; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Radiography; Tomography, Emission-Computed | 1996 |
67 other study(ies) available for deoxyglucose and Liver Neoplasms
Article | Year |
---|---|
Respiratory-gated PET imaging with reduced acquisition time for suspect malignancies: the first experience in application of total-body PET/CT.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2023 |
An Activatable Cancer-Targeted Hydrogen Peroxide Probe for Photoacoustic and Fluorescence Imaging.
Topics: Absorption, Radiation; Adenocarcinoma; Animals; Cell Line, Tumor; Deoxyglucose; Fluorescent Dyes; Heterografts; Humans; Hydrogen Peroxide; Liver Neoplasms; MCF-7 Cells; Mice; Mice, Nude; Molecular Imaging; Neoplasm Transplantation; Optical Imaging; Oxidative Stress; Photoacoustic Techniques; Piperazines; Tissue Distribution | 2019 |
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Deoxyglucose; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; GTP Phosphohydrolases; Humans; Liver Neoplasms; Mitochondria; Mitochondrial Dynamics; Mitochondrial Membrane Transport Proteins; Neoplasm Metastasis; Oxidative Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2020 |
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Nanoparticle Drug Delivery System; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Escape; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays | 2021 |
A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Topics: Cell Count; Cell Proliferation; Deoxyglucose; Estradiol; Estrogens; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Metabolome; Metabolomics; Nitriles; Oligomycins; Pyrazoles; Receptors, Estrogen; Transcriptome | 2021 |
The Combination of Glycolytic Inhibitor 2-Deoxyglucose and Microbubbles Increases the Effect of 5-Aminolevulinic Acid-Sonodynamic Therapy in Liver Cancer Cells.
Topics: Aminolevulinic Acid; Antimetabolites; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Deoxyglucose; Humans; Levulinic Acids; Liver Neoplasms; Microbubbles; Ultrasonic Therapy | 2017 |
Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.
Topics: Adenosine Triphosphate; ATP Synthetase Complexes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Deoxyglucose; Doxorubicin; Drug Resistance, Neoplasm; Energy Metabolism; Glycolysis; Humans; Ketone Oxidoreductases; Liver Neoplasms; Malates; Methotrexate; Oxidative Phosphorylation | 2018 |
18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Injections, Subcutaneous; Liver Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Omental splenosis after liver transplantation for hepatocellular carcinoma mimicking metastasis on fluoro-18-deoxyglucose positron emission tomography with computed tomography.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Metastasis; Omentum; Positron-Emission Tomography; Splenosis; Tomography, X-Ray Computed | 2019 |
Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Deoxyglucose; Drug Synergism; Enzyme Inhibitors; Glycolysis; Hep G2 Cells; Humans; Kinetics; Liver; Liver Neoplasms; Mitochondria, Liver; Molecular Targeted Therapy; Neoplasm Proteins; Organophosphorus Compounds | 2013 |
Two α-dicarbonyls downregulate migration, invasion, and adhesion of liver cancer cells in a p53-dependent manner.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Deoxyglucose; Down-Regulation; Drug Therapy, Combination; Genes, p53; Humans; Liver Neoplasms; Neoplasm Invasiveness; Pyruvaldehyde | 2013 |
Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism.
Topics: Animals; Apoptosis; Carcinogens; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Deoxyglucose; Glycolysis; Hypoxia; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Rats | 2015 |
Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.
Topics: 4-Chloro-7-nitrobenzofurazan; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Fluorescent Dyes; Glucose; Glucose Transporter Type 1; Humans; Liver Neoplasms; Precision Medicine | 2015 |
Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Glucokinase; Glycolysis; HeLa Cells; Hep G2 Cells; Hexokinase; Humans; Lactic Acid; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Neoplasm Transplantation; Triterpenes; Ursolic Acid | 2014 |
2-DG-Regulated RIP and c-FLIP Effect on Liver Cancer Cell Apoptosis Induced by TRAIL.
Topics: Adenosine Triphosphate; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Deoxyglucose; Flow Cytometry; Gene Silencing; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potentials; Mitochondria; Receptor-Interacting Protein Serine-Threonine Kinases; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand | 2015 |
pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery.
Topics: Animals; Cadmium Compounds; Cell Hypoxia; Cell Survival; Deoxyglucose; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Glucose Transporter Type 1; Hep G2 Cells; Humans; Hydrazones; Hydrogen-Ion Concentration; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Lysine; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Oxygen; Peptides; Polyethylene Glycols; Quantum Dots; RNA, Small Interfering; RNAi Therapeutics; Tellurium; Thioctic Acid; Time Factors; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; G1 Phase; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Resting Phase, Cell Cycle; Sorafenib | 2017 |
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Survival; Cellular Structures; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Electron Spin Resonance Spectroscopy; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoblotting; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxygen Consumption; RNA, Small Interfering; Sirtuin 1; Sirtuins; Tumor Cells, Cultured | 2008 |
Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line R
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Oxazines; Rats | 2012 |
[REACTIVE PROPERTIES OF 2-DESOXY-D-GLUCOSE-6PHOSPHATE IN HEPATOMAS AND EHRLICH-ASCITES CANCER CELLS].
Topics: Adenosine Triphosphate; Animals; Ascites; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Deoxyglucose; Glucose; Glucosephosphate Dehydrogenase; Liver Neoplasms; Metabolism; NADP; Neoplasms, Experimental; Rats; Research | 1964 |
ON THE MECHANISM OF ACTION 2-DEOXYGLUCOSE UPON TUMOUR CELLS.
Topics: Acetates; Adenosine Triphosphate; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Deoxyglucose; Glucose; Glycolysis; Liver Neoplasms; Metabolism; Mitochondria; Neoplasms, Experimental; Pharmacology; Research | 1964 |
Metabolism-enhanced tumor localization by fluorescence imaging: in vivo animal studies.
Topics: Animals; Deoxyglucose; Feasibility Studies; Fluorescent Dyes; Glycolysis; Hepatoblastoma; Humans; Liver Neoplasms; Mice; Mice, Nude; Photons; Scattering, Radiation; Sensitivity and Specificity; Spectroscopy, Near-Infrared | 2003 |
Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxyglucose; Drug Resistance, Multiple; Endoplasmic Reticulum; Glucose; Glycosylation; Humans; Liver Neoplasms; NF-kappa B; Oxidative Stress; Peptide Fragments; Proto-Oncogene Proteins c-jun; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation | 2003 |
2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Flow Cytometry; Humans; Liver Neoplasms; Microscopy, Electron, Transmission | 2005 |
Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Microscopy, Electron, Transmission | 2005 |
Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
Topics: Blotting, Northern; Carcinoma, Hepatocellular; Cell Line, Tumor; Dehydroepiandrosterone; Deoxyglucose; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Glucose-6-Phosphate; Humans; Liver Neoplasms; Protein Serine-Threonine Kinases; RNA, Messenger | 2005 |
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Topics: Adenosine Triphosphate; Antimetabolites; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Deoxyglucose; Drug Resistance, Neoplasm; Glucose-6-Phosphate Isomerase; Glycolysis; HeLa Cells; Hexokinase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Lactic Acid; Liver Neoplasms; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2007 |
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1982 |
Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells.
Topics: Animals; Antimetabolites; Antimetabolites, Antineoplastic; Chondroitin Sulfates; Deoxyglucose; Deoxyuridine; Etidronic Acid; Glycosaminoglycans; Glycosides; Heparitin Sulfate; Humans; Liver Neoplasms; Melanoma; Mice; Tumor Cells, Cultured | 1995 |
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphatase; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed | 1995 |
Insulin-like growth factor binding protein-1 from Hep G2 cells is potently inhibited by the truncated IGF-I analogue des-(1-3) IGF-I.
Topics: Analysis of Variance; Blotting, Northern; Carcinoma, Hepatocellular; Carrier Proteins; Culture Media; Deoxyglucose; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucose; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Liver Neoplasms; Peptide Fragments; Phenolsulfonphthalein; Radioimmunoassay; RNA; Somatomedins; Time Factors; Tumor Cells, Cultured | 1993 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
[Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Orbital Neoplasms; Organotechnetium Compounds; Predictive Value of Tests; Pyridoxal; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1994 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Topics: Confidence Intervals; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Models, Biological; Monte Carlo Method; Tomography, Emission-Computed | 1995 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
Modulation of the asialoglycoprotein receptor in human hepatoma cells: effect of glucose.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Binding Sites; Carcinoma, Hepatocellular; Culture Media; Cyclic GMP; Cycloheximide; Deoxyglucose; Glucose; Humans; Ligands; Liver Neoplasms; Precipitin Tests; Pyruvates; Pyruvic Acid; Receptors, Cell Surface; Tumor Cells, Cultured; Up-Regulation | 1994 |
Positron emission tomography in the clinical evaluation of metastatic cancer.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Models, Biological; Tomography, Emission-Computed | 1996 |
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Body Weight; Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Recombinant Proteins; Tomography, Emission-Computed | 1996 |
Quantification of serial tumor glucose metabolism.
Topics: Computer Simulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Models, Biological; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphatic Metastasis; Mediastinal Cyst; Mediastinal Neoplasms; Tomography, Emission-Computed | 1996 |
Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.
Topics: Adenocarcinoma; Chemoembolization, Therapeutic; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1996 |
[PET studies with C-11 ethanol in intratumoral therapy of hepatocellular carcinomas].
Topics: Aged; Blood Glucose; Brain; Brain Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyglucose; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 1996 |
'False-positive' uptake of FDG in a hepatic adenoma.
Topics: Adenoma; Adult; Breast Neoplasms; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Staging recurrent metastatic colorectal carcinoma with PET.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
False-negative fluorine-18-FDG PET in metastatic carcinoid.
Topics: Carcinoid Tumor; Deoxyglucose; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Cell cycle and growth stage-dependent changes in the transport of nucleosides, hypoxanthine, choline, and deoxyglucose in cultured Novikoff rat hepatoma cells.
Topics: Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Choline; Demecolcine; Deoxyglucose; DNA; Glucose; Hydroxyurea; Hypoxanthines; Kinetics; Liver Neoplasms; Mitosis; Neoplasms, Experimental; Nucleosides; Rats; Receptors, Drug; RNA, Neoplasm; Spectrometry, Fluorescence; Thymidine; Time Factors; Tritium; Uridine | 1975 |
Cyclic AMP, membrane transport and cell division. I. Effects of various chemicals on cyclic AMP levels and rate of transport of neucleosides, hypoxanthine and deoxyglucose in several lines of cultured cells.
Topics: Animals; Biological Transport, Active; Bucladesine; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cells, Cultured; Cyclic AMP; Cytochalasin B; Deoxy Sugars; Deoxyglucose; Depression, Chemical; Dipyridamole; Glioma; Hypoxanthines; Isoproterenol; L Cells; Liver Neoplasms; Mice; Papaverine; Prostaglandins; Rats; Thymidine; Uridine | 1975 |
The specific release of sialytransferase activity by human hepatoma cell lines.
Topics: Carcinoma, Hepatocellular; Cell Line; Child, Preschool; Chromatography, Gel; Cycloheximide; Deoxyglucose; Galactosyltransferases; Humans; Liver; Liver Neoplasms; Molecular Weight; Sialyltransferases; Subcellular Fractions; Transferases | 1979 |
Studies on the uptake of 2-deoxy-d-glucose in normal and malignant rat epithelial liver cells in culture.
Topics: Animals; Cell Division; Cells, Cultured; Deoxy Sugars; Deoxyglucose; Liver; Liver Neoplasms; Permeability; Rats; Time Factors | 1975 |
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver; Liver Neoplasms; Tomography, Emission-Computed | 1992 |
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
Intracellular targeting of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type.
Topics: Adipose Tissue; Animals; Biological Transport, Active; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Deoxyglucose; Fluorescent Antibody Technique; Genetic Vectors; Humans; Insulin; Liver Neoplasms; Mice; Microscopy, Electron; Monosaccharide Transport Proteins; Plasmids; Rats; Transfection | 1991 |
[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1991 |
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1991 |
Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells.
Topics: Animals; Base Sequence; Biological Transport; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Cloning, Molecular; Cricetinae; Deoxyglucose; DNA; Fibroblasts; Gene Expression; Genetic Vectors; Humans; Immune Sera; Immunoblotting; Insulin; Liver Neoplasms; Metallothionein; Molecular Sequence Data; Monosaccharide Transport Proteins; Transfection; Tumor Cells, Cultured | 1990 |
Insulin regulation of hexose transport in mouse 3T3-L1 cells expressing the human HepG2 glucose transporter.
Topics: Adipose Tissue; Animals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line; Cell Membrane; Cloning, Molecular; Deoxyglucose; Humans; Insulin; Liver Neoplasms; Mice; Molecular Weight; Monosaccharide Transport Proteins; RNA, Messenger; Transfection; Zinc | 1990 |
Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters.
Topics: Adipose Tissue; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Deoxyglucose; Female; Genes; Humans; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Multigene Family; Oocytes; Rats; RNA, Messenger; Tumor Cells, Cultured; Xenopus | 1989 |
Monokine regulation of glucose transporter mRNA in L6 myotubes.
Topics: Actins; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; Cells, Cultured; Deoxyglucose; Humans; Kinetics; Liver Neoplasms; Macrophages; Monokines; Monosaccharide Transport Proteins; Muscles; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 1989 |
[Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
Topics: Deoxy Sugars; Deoxyglucose; Embolization, Therapeutic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1989 |
Expression of the human erythrocyte glucose transporter in Escherichia coli.
Topics: Base Sequence; Carcinoma, Hepatocellular; Cloning, Molecular; Cytochalasin B; Deoxyglucose; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Escherichia coli; Gene Expression Regulation; Glucose; Humans; Immunoassay; Liver Neoplasms; Mercuric Chloride; Molecular Sequence Data; Monosaccharide Transport Proteins; Plasmids; Tumor Cells, Cultured | 1988 |
Imaging of hepatoma with 18F-fluorodeoxyglucose.
Topics: Carcinoma, Hepatocellular; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radioisotopes; Radionuclide Imaging | 1985 |
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed | 1986 |
Inhibition of transport systems in cultured rat hepatoma cells by colcemid and ethanol.
Topics: Animals; Biological Transport, Active; Carcinoma, Hepatocellular; Cell Line; Choline; Colchicine; Deoxyglucose; Depression, Chemical; Ethanol; Hypoxanthines; Liver Neoplasms; Mitosis; Neoplasms, Experimental; Rats; Tritium; Uridine | 1974 |